Pharmaceutical News and Articles

FDA Grants Interchangeable Designation to Yuflyma (adalimumab-aaty), Celltrion's Biosimilar to Humira (adalimumab)

FDA Announces Plan to Phase Out Some Animal Testing

The U.S. Food and Drug Administration announced it is shifting away from animal testing in the development of monoclonal antibody therapies and other drugs, fav

Mirum’s Livmarli Now FDA Approved in Tablet Formulation

Pfizer Discontinues Development of Oral GLP-1 Receptor Agonist Danuglipron

Pfizer Inc. (NYSE PFE) today announced the decision to discontinue development of danuglipron (PF-06882961), an oral glucagon-like peptide-1 (GLP-1) receptor ag

Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide

Ironwood Pharmaceuticals, Inc. (Nasdaq IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointest

FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as a First-Line Treatment for Unresectable or Metastatic Hepatocellular Carcinoma

Cancer Screening Rates Down Among American Adults

Cancer screenings are literal life savers, catching tumors early enough to cure patients and prevent deaths. Unfortunately, routine cancer screening rates have

American College of Physicians, April 3-5

The annual meeting of the American College of Physicians (Internal Medicine Meeting) was held from April 3 to 5 in New Orleans and was attended by internal medi

Hurricanes, Pandemic Led to Drop in CRC Incidence in Puerto Rico

Recent major events, including hurricanes Irma and Maria and the COVID-19 pandemic, were associated with a decreased incidence of colorectal cancer (CRC) in Pue

CDC Denies Milwaukee's Request for Help on Lead in Schools

When officials in Wisconsin s largest city asked the U.S. Centers for Disease Control and Prevention (CDC) for help dealing with high levels of lead in city sch